203
Views
12
CrossRef citations to date
0
Altmetric
Articles

Study about quinolone antibacterial agent modifying the Keggin polyoxotungstates

, , , , , & show all
Pages 602-611 | Received 06 Aug 2012, Accepted 05 Nov 2012, Published online: 25 Feb 2013
 

Abstract

Three new quinolone drug molecules modifying Keggin polyoxometalate compounds have been synthesized under hydrothermal conditions and structurally characterized. Single-crystal X-ray diffraction analysis shows that Keggin clusters modified by [Cu2(Enro)3H2O]4+ subunits result in formation of dimer {[Cu2(Enro)3H2O][SiW12O40]}2 in 1; in 2, Keggin clusters are modified by two [Cu(Norf)2]2+ subunits in the symmetrical coordinated mode, and then, discrete [Cu2(Norf)4][SiW12O40] is obtained; in 3, Keggin clusters are fused together via [Ni(Enro)2]2+ subunits giving the 1D drug-polyoxometalates (POMs) hybrid chain. Antitumor activities in vitro show that 3 exhibits good antitumor activity, while 1 and 2 and their parent SiW12 show no anti-SGC7901 or anti-SMMC7721 activities, indicating that the antitumor activities rest on differences of metal ions, differently affecting electron transfer between quinolone and POMs.

Acknowledgements

This study is financially supported by the National Natural Science Foundation (Grant No. 21271089), the Scientific and technological innovation team (2012TD010) and Postdoctoral Foundation in Heilongjiang Province.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.